Carregant...
Serum sRANKL and sRANKL/OPG ratio: Novel biomarkers in non-small cell lung cancer
Osteoprotegerin (OPG) and soluble receptor activator of nuclear factor-κB ligand (sRANKL) are bone-regulating molecules. The two molecules have each been indicated to be involved in carcinogenesis. However, the diagnostic significance in non-small cell lung cancer (NSCLC) remains to be investigated....
Guardat en:
| Publicat a: | Oncol Lett |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774468/ https://ncbi.nlm.nih.gov/pubmed/26998159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4166 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|